The effects of anemia and blood transfusion on patients with stage III-IV ovarian cancer.
about
How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology.Nrf2 induces cisplatin resistance via suppressing the iron export related gene SLC40A1 in ovarian cancer cells.Optimizing Blood Transfusion Practices Through Bundled Intervention Implementation in Patients With Gynecologic Cancer Undergoing Laparotomy.Pre-treatment hemoglobin levels are an independent prognostic factor in patients with non-small cell lung cancer.Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients with Lung Adenocarcinoma.
P2860
The effects of anemia and blood transfusion on patients with stage III-IV ovarian cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
The effects of anemia and blood transfusion on patients with stage III-IV ovarian cancer.
@en
type
label
The effects of anemia and blood transfusion on patients with stage III-IV ovarian cancer.
@en
prefLabel
The effects of anemia and blood transfusion on patients with stage III-IV ovarian cancer.
@en
P2093
P50
P1476
The effects of anemia and blood transfusion on patients with stage III-IV ovarian cancer
@en
P2093
Jill Nation
Pamela Chu
Prafull Ghatage
P304
P356
10.1097/IGC.0B013E3182A57FF6
P577
2013-11-01T00:00:00Z